Titel des Posters: „The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: rationale and results from an enhanced TiRP model“ (Poster #118P)
Präsentation des Posters: 12. Dezember, 12:15 Uhr
Referent: Dr. Andriy Krendyukov, VP Cqphbah Qwapmdt, Tjqfsxcw LL